HemOnc--Pharmacology Flashcards
heparin moa?
cofactor for atIII, decreases thrombin and factor Xa
direct thrombin inhibitors
argatroban, bivalirudin–derivatives of hirudin
in HIT, what to use for anticoagulation?
argatroban or bivalirudin
warfarin moa?
interferes with synthesis and gamma-carboxlyation of vitamin K dependent clotting factors (2, 7, 9, 10 and proteins C and S)
how to follow warfarin effect?
extrinsic pathway–use PT/INR to monitor
warfarin tox?
bleeding, teratogenic (do not use in preg); skin/tissue necrosis esp if patient has genetic protein C/S deficiency; drug-drug interactions
Direct factor Xa inhibitors?
apixaban, rivaroxaban;
aspirin overdose? A/B derrangement
initially a respiratory alkalosis then superimposed by metabolic acidosis
ADP receptor inhibitors? moa?
clopidogrel, ticlopidine, prasugrel, ticagrelor; inhibits platelet aggregation by irreversibly blocking ADP receptors and prevents GPIIb/IIIa receptor expression, preventing fibrinogen binding
ADP receptor inhibitor that can cause neutropenia?
ticlopidine
ADP receptor inhibitors can cause..?
TTP or HUS
cilostazol, dipyradamole?
PDEIII inhibitors, increase cAMP in platelets–>inhibiting platelet aggregation; also vasodilates
GP IIb/IIIa inhibitors?
abciximab,eptifibatide, tirofiban; can cause thrombocytopenia
Cell cycle effect: vinca alkaloids and taxols
inhibit M phase
Cell cycle effect: antimetabolites
S phase; eg MTX, 5-FU, cytarabine, 6MP, 6TG, hdroxyurea
Cell cycle effect: etoposide
S and G2 phase
Cell cycle effect: bleomycin
G2 phase
methotrexate moa?
folic acid analog that inhibits DHF reductase–>decreases dTMP–>decreases DNA and protein synthesis
methotrexate tox?
myelosuppression (reverse with folinic acid); macrovesicular fatty change in liver, mucositis, teratogen
5-FU moa?
pyrimide analog bioactivated to 5F-dUMP which covalently complexes folic acid to inhibit thymidylate synthase–>decrease dTMP–>decrease DNA and protein synthesis
5FU tox?
myelosupression which cannot be reversed with folinic acid; overdose rescue with uridine; photosensitivty